Cargando…

Urinary cGMP concentrations after exposure to radio-contrast media in patient at risk for contrast media induced nephropathy (CIN) predicts 90-day morbidity and mortality

Detalles Bibliográficos
Autores principales:	Hocher, Berthold, Heunisch, Fabian, von Einem, Gina-Franziska, Alter, Markus, Keim, Yvonne, Stasch, Johannes-Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765622/ http://dx.doi.org/10.1186/2050-6511-14-S1-P29

Ejemplares similares

Urinary cGMP predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus before exposure to contrast medium
por: Chaykovska, Lyubov, et al.
Publicado: (2018)

The molecular mechanism of contrast-induced nephropathy (CIN) and its link to in vitro studies on iodinated contrast media (CM)
por: Yang, Jai-Sing, et al.
Publicado: (2018)

Urinary Vitamin D Binding Protein and KIM-1 Are Potent New Biomarkers of Major Adverse Renal Events in Patients Undergoing Coronary Angiography
por: Chaykovska, Lyubov, et al.
Publicado: (2016)

ADMA predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus undergoing coronary angiography
por: Heunisch, Fabian, et al.
Publicado: (2017)

Inhibition of the TGFβ signalling pathway by cGMP and cGMP‐dependent kinase I in renal fibrosis
por: Schinner, Elisabeth, et al.
Publicado: (2017)

Contrast Media: Are There Differences in Nephrotoxicity among Contrast Media?
por: Solomon, Richard
Publicado: (2014)

Evaluation of the protective effect of N-acetylcysteine on contrast media nephropathy
por: Pezeshgi, Aiyoub, et al.
Publicado: (2015)

Biomarkers in the prediction of contrast media induced nephropathy – the BITCOIN study
por: Seibert, Felix S., et al.
Publicado: (2020)

Safe Limits of Contrast Media for Contrast-Induced Nephropathy: A Multicenter Prospective Cohort Study
por: Nie, Zhiqiang, et al.
Publicado: (2021)

Endogenous and Exogenous Antioxidants as Agents Preventing the Negative Effects of Contrast Media (Contrast-Induced Nephropathy)
por: Panova, Ina G., et al.
Publicado: (2023)

Analysis of cross-reactivity between radio -contrast media in 97 hypersensitivity reactions
por: Lerondeau, Berangere, et al.
Publicado: (2014)

Impact of anemia on contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions
por: Li, Wen-hua, et al.
Publicado: (2012)

Retrospective analysis of the efficacy of radio-contrast-induced nephropathy prophylaxis
por: Wood, J, et al.
Publicado: (2015)

NO/cGMP signalling in platelets
por: Schinner, Elisabeth, et al.
Publicado: (2009)

cGMP and cardiac hypertrophy
por: Perera, Ruwan K, et al.
Publicado: (2015)

Medical contrast media as possible tools for SAXS contrast variation
por: Gabel, Frank, et al.
Publicado: (2019)

Analysis of cGMP signalling with transgenic mice expressing FRET-based cGMP sensors
por: Wen, Lai, et al.
Publicado: (2013)

In vivo monitoring of sorafenib therapy effects on experimental prostate carcinomas using dynamic contrast-enhanced MRI and macromolecular contrast media
por: Cyran, Clemens C., et al.
Publicado: (2013)

Contrast Induced Nephropathy with Intravenous Iodinated Contrast Media in Routine Diagnostic Imaging: An Initial Experience in a Tertiary Care Hospital
por: Bhatt, Shuchi, et al.
Publicado: (2016)

Contrast enhancement efficacy of iodinated contrast media: Effect of molecular structure on contrast enhancement
por: Imai, Kuniharu, et al.
Publicado: (2018)

Side Effects of Radiographic Contrast Media
por: Andreucci, Michele
Publicado: (2014)

The involvement of osmolarity in the safety of contrast media
por: Isola, Stefania, et al.
Publicado: (2018)

Liver Imaging and Hepatobiliary Contrast Media
por: Pastor, Catherine M., et al.
Publicado: (2018)

Hypersensitivity to Gadolinium-Based Contrast Media
por: Gracia Bara, M. Teresa, et al.
Publicado: (2022)

Hypersensitivity Reactions to Iodinated Contrast Media
por: Chiu, Tsu-Man, et al.
Publicado: (2022)

Transient kinetics of a cGMP-dependent cGMP-specific phosphodiesterase from Dictyostelium discoideum
Publicado: (1984)

Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling
por: Mullershausen, Florian, et al.
Publicado: (2003)

Contrast media-induced nephropathy in Tunisia: prospective case-control study with cardio-nephrological monitoring
por: Hajji, Meriam, et al.
Publicado: (2023)

PDE5 says NO to cGMP
por: LeBrasseur, Nicole
Publicado: (2003)

cGMP steers axons home
por: LeBrasseur, Nicole
Publicado: (2002)

A novel pathway of cGMP
por: Kuhn, Michaela, et al.
Publicado: (2011)

The role of cGMP and PKG in cardioprotection
por: Downey, James M, et al.
Publicado: (2009)

NO-cGMP signalling and cancer therapy
por: Bian, Ka, et al.
Publicado: (2013)

Role of cGMP in fat and metabolism
por: Pfeifer, Alexander, et al.
Publicado: (2013)

cGMP Signaling in Photoreceptor Degeneration
por: Li, Shujuan, et al.
Publicado: (2023)

cGMP: a unique 2nd messenger molecule – recent developments in cGMP research and development
por: Friebe, Andreas, et al.
Publicado: (2019)

Systemic drug-related intertriginous and flexural exanthema from radio contrast media: A series of 3 cases
por: Huynh, Thy, et al.
Publicado: (2015)

Contrast Induced Nephropathy and 2-Year Outcomes of Iso-Osmolar Compared with Low-Osmolar Contrast Media after Elective Percutaneous Coronary Intervention
por: Du, Mengyang, et al.
Publicado: (2020)

Biomarkers in two different animal models of pulmonary arterial hypertension (PAH) under treatment with a cGMP enhancing substance
por: Grupe, Julia, et al.
Publicado: (2011)

Web review: Contrast media in radiology and imaging
por: Indrajit, IK
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_dcq8iscfbm2cbl7q0q4qsvr8dp